Literature DB >> 789875

Achievements of cancer chemotherapy.

J S Tobias, J M Whitehouse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 789875      PMCID: PMC5368771     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


× No keyword cloud information.
  68 in total

1.  Hemisulfur mustard in the palliation of patients with metastatic ovarian carcinoma.

Authors:  T H GREEN
Journal:  Obstet Gynecol       Date:  1959-04       Impact factor: 7.661

2.  The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides.

Authors:  A Gilman; F S Philips
Journal:  Science       Date:  1946-04-05       Impact factor: 47.728

3.  Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.

Authors:  F M Muggia; M Perloff; G A Chia; L J Reed; G C Escher
Journal:  Cancer Chemother Rep       Date:  1974 Nov-Dec

4.  Prevention of gestational trophoblastic disease by use of actinomycin D in molar pregnancies.

Authors:  D P Goldstein
Journal:  Obstet Gynecol       Date:  1974-04       Impact factor: 7.661

Review 5.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

6.  Rhabdomyosarcoma in children. Improved outlook with a multidisciplinary approach.

Authors:  N Jaffe; R M Filler; S Farber; D G Traggis; G F Vawter; M Tefft; J E Murray
Journal:  Am J Surg       Date:  1973-04       Impact factor: 2.565

7.  Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.

Authors:  R E Beck; D A Boyes
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

8.  Studies on bleomycin.

Authors:  H Umezawa; M Ishizuka; K Maeda; T Takeuchi
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

9.  Cytological and functional criteria for the classification of malignant lymphomata.

Authors:  K Lennert; H Stein; E Kaiserling
Journal:  Br J Cancer Suppl       Date:  1975-03

10.  Advanced ovarian cancer: primary treatment with surgery, radiotherapy, and chemotherapy.

Authors:  C T Griffiths; R H Grogan; T C Hall
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.